Mylan will acquire drugmaker Aspen Pharmacare's European thrombosis business for $757 million.

Gold surges to an all-time high amid worsening U.S.-China tensions; Wall Street prepares for a week heavy on tech earnings; Moderna secures an additional $472 million to develop a coronavirus vaccine.

Biogen is downgraded to equal weight by Barclays, which cited an adverse MS-drug patent ruling.

A U.S. District Court judge rules that Mylan proved claims for Biogen’s patent for Tecfidera are invalid for 'lack of written description.'

Mylan, Teva, Taro and Perrigo are among those accused of price-fixing, market allocation and bid-rigging on 80 topical drugs.

Gilead announced the drugmakers that will receive non-exclusive voluntary licenses to manufacture remdesivir in 127 countries.

Mylan said that the coronavirus pandemic helped its bottom line in Europe.

Stock futures suggest a lower start for Wall Street; Under Armour reports earnings; Stage Stores files for bankruptcy.

Mylan was sliding Friday after beating Wall Street's fourth quarter earnings expectations, but missing on revenue.

Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.

Electric-truck manufacturer Nikola, like the broad vehicle industry, has been struggling with supply-chain issues.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.